Yield Theory

Health Care stock comparison

MTD vs SYK: which business are you actually underwriting?

Compare Mettler-Toledo International Inc. with Stryker Corporation using their business models, SEC classifications, fiscal calendars, current primary filings, and the research questions that matter. This is a thesis framework—not a price target or automatic winner.
Sector
Health
Industry
Different SIC
Shared themes
1
Updated
2026-02-11

MTD vs SYK: quick comparison

Company factMTDSYK
CompanyMettler-Toledo International Inc.Stryker Corporation
ExchangeNYSENYSE
SEC industryLaboratory Analytical InstrumentsSurgical & Medical Instruments & Apparatus
Fiscal year-endDecember 31December 31
Latest annual filing10-K · 2026-02-0610-K · 2026-02-11

MTD vs SYK: audited financials

SYK reported about 6.2× the revenue of MTD in the latest audited fiscal year. On profitability, MTD converted a larger share of revenue into net income (21.6% versus 12.9%). Scale and margin are starting facts for the thesis, not the verdict.

MetricMTDSYK
Revenue$4.0B$25.1B
Net income$869M$3.2B
Operating cash flow$956M$5.0B
Diluted EPS$42.05$8.40
Net margin21.6%12.9%

MTD: FY ending 2025-12-31 · SYK: FY ending 2025-12-31. Figures as tagged in each issuer's SEC XBRL filing; fiscal calendars may not align.

How the businesses differ

Why this pair belongs in the comparison set

MTD and SYK have different SEC industry classifications, but both map to the maintained International markets research theme inside the Health Care sector. A shared classification or theme makes the pair useful for a defined research question; it does not mean the companies have identical products, economics, or risks.

Mettler-Toledo International Inc. (MTD)

Mettler-Toledo makes precision instruments and weighing systems for labs and industrial customers.

Stryker Corporation (SYK)

Stryker makes orthopedic implants, surgical equipment, and medical devices for hospitals.

The useful starting point is not which ticker has performed better. It is whether the two companies convert the same economic forces into revenue and cash flow in the same way. MTD is classified by the SEC as Laboratory Analytical Instruments, while SYK is classified as Surgical & Medical Instruments & Apparatus. The different industry codes are a warning against treating sector membership as proof of identical economics.

Members-only research

What members are reading this month

The thesis, the numbers behind it, and what would break it. Full access is $15 a month.

Read the full research

Which thesis does each company fit?

Use the distinction below to decide which filing deserves deeper work. It is a research routing rule, not a recommendation or prediction.

Study MTD when…

  • Drug approvals and clinical-trial readouts
  • Medicare and drug-pricing policy
  • Demographics and an aging population
  • GLP-1 and obesity-drug demand

Study SYK when…

  • Drug approvals and clinical-trial readouts
  • Medicare and drug-pricing policy
  • Demographics and an aging population
  • GLP-1 and obesity-drug demand

Shared research themes

International markets

SEC filing comparison and disclosure evidence

Start with primary filings because fiscal calendars and accounting presentation can make superficially similar quarters incomparable.MTD's fiscal year ends December 31, while SYK's ends December 31. Normalize the reporting periods before comparing growth, margins, capital intensity, or guidance.

The current verified House and Senate snapshot contains 6matched transaction rows for MTDand 24 for SYK. These delayed, range-based disclosures can identify a filing to inspect; they do not establish motive, conviction, or a real-time trading signal.

What this comparison cannot tell you

This page does not contain licensed live prices, a valuation model, earnings estimates, portfolio constraints, or a forecast of future returns. SEC classifications can be broad, company descriptions can lag strategic change, and the latest annual filing may predate a material acquisition or divestiture. Read subsequent quarterly and current reports before making a decision.

A stronger business is not automatically the better stock. Starting valuation, expectations, capital structure, cyclicality, dilution, and the probability of each thesis determine the investment outcome. Use this comparison to frame the work, then verify the numbers in the linked filings and current company disclosures.

MTD vs SYK FAQs

Are MTD and SYK direct competitors?

Mettler-Toledo International Inc. and Stryker Corporation sit in the same Health Care sector but have different SEC industry classifications. The comparison is most useful for portfolio role and sector exposure, not as a claim that every product competes directly.

Which is better, MTD or SYK?

There is no context-free winner. Compare the operating exposures, filing evidence, valuation, balance sheet, and risks against the specific thesis you are testing. This page deliberately does not turn a static profile into a buy or sell recommendation.

Does this MTD vs SYK comparison include live prices?

No. Yield Theory does not republish unlicensed real-time market data. The financial figures on this page are the audited annual numbers Mettler-Toledo International Inc. and Stryker Corporation tagged in their SEC XBRL filings. Use a regulated broker or licensed quote provider for current prices and valuation multiples.

Where does the company information come from?

Company classifications, fiscal year-ends, and filing links come from the SEC EDGAR submissions API snapshot refreshed 2026-09-25. Business summaries and research themes are maintained by Yield Theory.

Data snapshot: SEC EDGAR submissions API, refreshed 2026-09-25. Independent educational research; not investment advice.

A comparison is the setup. The thesis is the call.

MTD vs SYK shows how the businesses differ. Membership is the monthly sourced view of who could benefit, what could break, and what evidence matters next. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included